Presentation is loading. Please wait.

Presentation is loading. Please wait.

The Dealy Strategy Group LLC Presentation to Health TechNet

Similar presentations


Presentation on theme: "The Dealy Strategy Group LLC Presentation to Health TechNet"— Presentation transcript:

1 www.dealystrategy.com, lisa.ghezzi@dealystrategy.com
The Dealy Strategy Group LLC Presentation to Health TechNet March 21, 2000 by Lisa Marie Ghezzi The DEALY STRATEGY GROUP LLC, March 21, 2000

2 Venture Capital Investment Trends
Increasing Funds Raised and Invested Internet-related firms receive a majority of funds Healthcare Industry related investments increase over 1998 Venture Capital increasingly important to driving economic development The DEALY STRATEGY GROUP LLC, March 21, 2000

3 Venture Capital Funds Raised
Source: National Venture Capital Association The DEALY STRATEGY GROUP LLC, March 21, 2000

4 Companies Receiving Funding
Source: National Venture Capital Association, Venture Economics The DEALY STRATEGY GROUP LLC, March 21, 2000

5 Venture Capital Investments
1999 Total Investments 2.5 times Investments in 1998 Source: National Venture Capital Association The DEALY STRATEGY GROUP LLC, March 21, 2000

6 Venture Capital Financing by Industry Sector
Source: National Venture Capital Association, Venture Economics * Internet Specific - companies that would not exist without the Internet and that would not fit in any other industry sector; Internet related companies are found in all industry sectors; total investment $31.9B compared to $7.0B in 1998. The DEALY STRATEGY GROUP LLC, March 21, 2000

7 Venture Capital Investment in Healthcare Industry
Source: National Venture Capital Association, Venture Economics The DEALY STRATEGY GROUP LLC, March 21, 2000

8 Venture Capital Financing by Region
Every region experienced a minimum of 60% growth. Leaders: Northern California % Northwest - 210% Mid-Atlantic % Average venture size varies by region (1/99 - 9/99): Mid-Atlantic led with $13M Southern California -- exceeding $12M Northern California, NE and Rocky Mt -- $11M SW, NW, Midwest and SE -- range from $8 to $9.5M Growth in investments is indicative that the entrepreneurial communities are maturing -- supported by strong technology community, educated workforce and efficient infrastructure Source: National Venture Capital Association, Venture Economics The DEALY STRATEGY GROUP LLC, March 21, 2000

9 Internet vs. Non-Internet Venture Capital Investments by Region
Internet-related Venture Capital financing in the Mid-Atlantic ranked 4th with $2.2B (roughly 55%); non-Internet investments -- $1.8B, or 45%. Mid-Atlantic ranked among the highest for non-Internet-related investments. Source: National Venture Capital Association, Venture Economics The DEALY STRATEGY GROUP LLC, March 21, 2000

10 VC Investment Increases Drive Economic Growth
Greater number of Venture-backed companies go public in 1999 compared to earlier years -- 50% vs. 21% and 22% in 1998 and 1997 respectively. Median age of venture-backed company was 4 years compared to 4.5 years in 1998; 5 years in compare to 10.5 years in 1994; Internet company short life is greatly contributing to this -- in 1999, the Internet-related company was 4.3 years to IPO, vs. the Non-Internet-related company at 7.6 years. Increasing number of IPOs allows for quicker liquidity and reinvestment into new opportunities. Source: National Venture Capital Association, Venture Economics The DEALY STRATEGY GROUP LLC, March 21, 2000

11 Average Offering and Valuation of Venture-backed Companies Increasing
Average offering size was 77% greater than in 1998 Average post offer valuation was over 2x that of 1998 Note: numbers may be slightly off due to rounding Source: National Venture Capital Association, Venture Economics The DEALY STRATEGY GROUP LLC, March 21, 2000

12 Top Venture Capital Firms
Source: National Venture Capital Association, Venture Economics The DEALY STRATEGY GROUP LLC, March 21, 2000

13 Top Venture Capital Firms Investing in Healthcare/Medical/Biotech
Chase Hambrecht & Quist primary venture investing vehicle is Access Technology Partners, L.P., $330M fund health/bio: biotechnology, bio-informatics, pharmaceuticals, medical devices, and drug delivery, and information, management, and outsourcing services The DEALY STRATEGY GROUP LLC, March 21, 2000

14 Top Venture Capital Firms Investing in Healthcare/Medical/Biotech
New Enterprise Associates investment focus: medical and life sciences -- biotechnology, pharmaceuticals, healthcare services, medical devices, instrumentation and information management stage: principally in early stage companies Three Primary questions asked: Will the company change the way people behave, via a unique product or service? Is there an unbounded opportunity, reflected by a large potential market, manageable competition and reasonable capital requirements? Is there a quality management team with experience and breadth? Are they people NEA can work with "through thick and thin" - especially thin? The DEALY STRATEGY GROUP LLC, March 21, 2000

15 Top Venture Capital Firms Investing in Healthcare/Medical/Biotech
Sequoia investment focus: biotechnology, medical devices, services (primarily B2B), software instrumentation and information management) makes 8 to 10 investments each year along with 12 to 15 follow-on investments stage: very early stages investing partners include: Kleiner, Perkins, Caulfield & Byers The DEALY STRATEGY GROUP LLC, March 21, 2000

16 Top Venture Capital Firms Investing in Healthcare/Medical/Biotech
Kleiner, Perkins, Caulfield & Byers investment focus: life sciences -- medical devices and diagnostics, drug discoveries and therapeutics, health care services and informatics investing partners include: Sequoia, Weiss Peck & Greer Venture Partners corporate partners through JAVA fund “Keiretsu” approach -- shared information and knowledge, network of 175 companies and 1000s executives The DEALY STRATEGY GROUP LLC, March 21, 2000

17 Top Venture Capital Firms Investing in Healthcare/Medical/Biotech
Integral Partners: investment focus: life sciences sector -- emerging medical technologies and health care information systems; diseases -- particularly active with companies targeting the cardiology and oncology markets. stage: expansion-stage private and growth-stage public investing partners include: Kleiner, Perkins, Caulfield & Byers, Silver Lake Partners The DEALY STRATEGY GROUP LLC, March 21, 2000


Download ppt "The Dealy Strategy Group LLC Presentation to Health TechNet"

Similar presentations


Ads by Google